Cronos Group Future Growth
Future criteria checks 3/6
Cronos Group is forecast to grow earnings and revenue by 95.2% and 8.7% per annum respectively while EPS is expected to grow by 100.2% per annum.
Key information
95.2%
Earnings growth rate
100.2%
EPS growth rate
Pharmaceuticals earnings growth | 23.9% |
Revenue growth rate | 8.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 05 Dec 2024 |
Recent future growth updates
Recent updates
Cronos Group Is Probably Undervalued As Liquidity Swells
Dec 05Buy Cronos Stock Before It Surges Higher
Aug 20Cronos Group: An Intriguing Value Opportunity
Jun 17Cronos Stock: Attractive Now With Cannabis Legalization In Germany
Mar 04Cronos Group: Flush With Cash And Trading Below Book Value
Feb 11Cronos Group GAAP EPS of -$0.05 beats by $0.01, revenue of $23.1M misses by $5.25M
Aug 09Cronos Group: Too Much Cash, Too Soon - Making The Bear Case
Aug 01Cronos Group: High Hurdles
May 11Cronos Earnings: Cannabis Stock With 65% Net Cash And 51% Revenue Growth
Mar 01Cronos Group Late-Filed Q3-2021 Earnings Show Revenues From Synthetic Cannabinoids
Feb 22Cronos Group: Still No Reason To Own
Jan 22Cronos Group Strategic Investor Altria May Be About To Buy The Balance
Nov 08After Cronos Finally Invests In U.S. Cannabis, Is The Stock A Buy?
Aug 30Is Cronos Stock Worth Buying? Probably, But Patience Remains A Requirement
Jul 12Cronos Group stock rises 2.6% with acquisition of 10.5% stake in PharmaCann
Jun 14Cronos Group: Still Hasn't Launched
May 09Cronos Group Q1 Earnings Preview
May 06Cronos: The Most Confusing Cannabis Stock
Apr 28Cronos: Sitting On Your Hands Is Not A Winning Strategy
Jan 03Cronos Group (CRON) Investor Presentation - Slideshow
Nov 24Cronos Is A Buy With Increasing Revenues
Nov 18Cronos shares rise 5% on solid Q3 beat; top-line +96% boosted by advancement in Canadian/Israeli market
Nov 05Cronos: Failure To Launch
Nov 03Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 136 | 21 | N/A | 17 | 1 |
12/31/2025 | 141 | 10 | 4 | 12 | 3 |
12/31/2024 | 123 | -13 | -3 | 23 | 3 |
9/30/2024 | 111 | -48 | 17 | 28 | N/A |
6/30/2024 | 102 | -57 | 11 | 16 | N/A |
3/31/2024 | 93 | -54 | -2 | 3 | N/A |
12/31/2023 | 87 | -70 | -46 | -43 | N/A |
9/30/2023 | 85 | -101 | -86 | -84 | N/A |
6/30/2023 | 81 | -133 | -101 | -97 | N/A |
3/31/2023 | 84 | -145 | -108 | -103 | N/A |
12/31/2022 | 87 | -155 | -94 | -89 | N/A |
9/30/2022 | 91 | -213 | -105 | -101 | N/A |
6/30/2022 | 91 | -102 | -124 | -119 | N/A |
3/31/2022 | 85 | -263 | -147 | -141 | N/A |
12/31/2021 | 65 | -127 | -166 | -154 | N/A |
9/30/2021 | 66 | -373 | -179 | -156 | N/A |
6/30/2021 | 57 | -381 | -181 | -153 | N/A |
3/31/2021 | 51 | -310 | -188 | -153 | N/A |
12/31/2020 | 47 | -72 | -180 | -145 | N/A |
9/30/2020 | 37 | 101 | -185 | -160 | N/A |
6/30/2020 | 31 | 636 | -186 | -152 | N/A |
3/31/2020 | 29 | 929 | -192 | -155 | N/A |
12/31/2019 | 24 | 1,167 | -170 | -131 | N/A |
9/30/2019 | 21 | 1,089 | -131 | -59 | N/A |
6/30/2019 | 18 | 479 | -130 | -49 | N/A |
3/31/2019 | 13 | 293 | -104 | -11 | N/A |
12/31/2018 | 12 | -21 | -96 | -8 | N/A |
9/30/2018 | 9 | -8 | -103 | -28 | N/A |
6/30/2018 | 7 | -1 | N/A | -16 | N/A |
3/31/2018 | 5 | -2 | N/A | -13 | N/A |
12/31/2017 | 3 | -1 | N/A | -4 | N/A |
9/30/2017 | 4 | 1 | N/A | -4 | N/A |
6/30/2017 | 2 | 0 | N/A | -8 | N/A |
3/31/2017 | 1 | -1 | N/A | -6 | N/A |
12/31/2016 | 0 | -1 | N/A | -5 | N/A |
9/30/2016 | 2 | 0 | N/A | -3 | N/A |
6/30/2016 | 2 | 0 | N/A | -2 | N/A |
3/31/2016 | 3 | 1 | N/A | -1 | N/A |
12/31/2015 | 2 | 0 | N/A | -1 | N/A |
9/30/2015 | 0 | -4 | N/A | -2 | N/A |
6/30/2015 | -1 | -4 | N/A | -2 | N/A |
3/31/2015 | -1 | -4 | N/A | -2 | N/A |
12/31/2014 | -1 | -4 | N/A | -1 | N/A |
9/30/2014 | 0 | -2 | N/A | -1 | N/A |
6/30/2014 | 0 | -1 | N/A | -1 | N/A |
12/31/2013 | 0 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRON is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: CRON is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CRON is expected to become profitable in the next 3 years.
Revenue vs Market: CRON's revenue (8.7% per year) is forecast to grow slower than the US market (9.1% per year).
High Growth Revenue: CRON's revenue (8.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CRON's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 05:28 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cronos Group Inc. is covered by 20 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Vahan Ajamian | Beacon Securities Limited |
Tamy Chen | BMO Capital Markets Equity Research |
Lisa Lewandowski | BofA Global Research |